Features of Regenerated Clones with or without Fusion Treatment between Auxotrophic Mutants of Streptomyces antibioticus and Their Antibiotic Productivity(Microbiology & Fermentation Industry)
スポンサーリンク
概要
- 論文の詳細を見る
During experiments on protoplast fusion of complementary auxotrophic mutants (194 and 11M-21) of Streptomyces antibioticus for strain improvement, the clones (typified by F-40) regenerated on minimal regeneration medium (MRM) were found to be prototrophs, and to produce an antibiotic different from those produced by the parent strain. The protoplast regeneration of each parent was examined as a negative control experiment. In the regenerated clones of 194, half of them produced actinomycins similar to those produced by the original mutant 194, but others (typified by R-20) seemed to produce antibiotics similar to those produced by F-40. In the taxonomic characterization of morphological, cultural, and physiological properties of each strain, F-40, R-20, and the parent mutant 194 had no significant differences with a few exceptions. The problem here is whether the antibiotic of R-20 is the same as that of F-40, which was first isolated and found to be a peptide antibiotic different from actinomycins, with activity against Gram-negative and Gram-positive bacteria.
- 社団法人日本農芸化学会の論文
- 1990-11-23
著者
-
Shibata Motoo
Laboratory Of Medicinal Microbiology Faculty Of Pharmaceutical Sciences Kumamoto University
-
Shoji Shozo
Laboratory Of Medicinal Microbiology Faculty Of Pharmaceutical Sciences Kumamoto University
-
Kubota Yukiho
Laboratory Of Medicinal Microbiology Faculty Of Pharmaceutical Sciences Kumamoto University
-
FUJIMOTO Yuki
Laboratory of Medicinal Microbiology, Faculty of Pharmaceutical Sciences, Kumamoto University
-
IMAMURA Akihiro
Laboratory of Medicinal Microbiology, Faculty of Pharmaceutical Sciences, Kumamoto University
-
IYEIRI Chiharu
Laboratory of Medicinal Microbiology, Faculty of Pharmaceutical Sciences, Kumamoto University
-
Imamura Akihiro
Laboratory Of Medicinal Microbiology Faculty Of Pharmaceutical Sciences Kumamoto University
-
Fujimoto Yuki
Laboratory Of Medicinal Microbiology Faculty Of Pharmaceutical Sciences Kumamoto University
-
Iyeiri Chiharu
Laboratory Of Medicinal Microbiology Faculty Of Pharmaceutical Sciences Kumamoto University
関連論文
- Effect of Validamycin on β-d-Glucan-degrading Enzymes from Rhizoctonia solani
- HAF, Hepatoma Aggregation Factor Produced by Streptomyces sp. Strain No. A-6143(Biological Chemistry)
- 3315-AF2, a Cell Aggregation Factor Produced by Streptomyces sp. Strain No.A-3315(Biological Chemistry)
- Effects of Validamycin on Glucan Synthesis by Cell-free Extracts from Rhizoctonia solani(Biological Chemistry)
- Cell Aggregation Factor Produced by Streptomyces sp. Strain No.A-3315(Biological Chemistry)
- Characteristics and Action Mechanism of SAF, Cell Aggregation Factor Produced by Streptomyces murinus Strain No.A-2805(Biological Chemistry)
- SAF, a New Cell Aggregation Factor Produced by Streptomyces murinus Strain No. A-2805(Biological Chemistry)
- Characterization of B-1625 FA_, an Acidic Actinomycin Congener(Microbiology & Fermentation Industry)
- Serratia marcescens-Lytic Enzyme Produced by Micromonospor sp. Strain No. 152
- Partial Amino Acid Sequence of an Alkaline Protease Inhibitor, API-2 (b and c)
- Features of Regenerated Clones with or without Fusion Treatment between Auxotrophic Mutants of Streptomyces antibioticus and Their Antibiotic Productivity(Microbiology & Fermentation Industry)
- Amino Sugar Components and Characterization of Antibiotic K-52B
- Production of Acidic Actinomycin Congeners by a Mutant Strain of Streptomyces antibioticus, No. B-1625
- M-GCI, a Novel β-Glucuronidase Inhibitor Produced by Micromonospora sp. Strain No. BR-1613
- Purification and Properties of Lipase Activator Produced by Streptomyces sp. Strain No. BR-1381
- Serratia-lytic Enzyme Produced by Streptomyces sp. Strain No. 177
- Action of Lipase Activator (LAV) Produced by Streptomyces sp. Strain No. BR-1381 on Phycomyces nitens Lipase
- Selectively Increased Production of Acidic Actinomycin Congener, B-1625 FA2β, on Combined Use of Sarcosine and Ferrous Sulfate